Logo Image
Commentary|Slideshows|April 10, 2026

Molecular Imaging in Focus Series: The First Three Episodes

Catch up on the first three episodes of our Molecular Imaging in Focus series featuring interviews with Gary Ulaner, MD, PhD, Louise Emmett, MBChB, FRACP, FAANMS, MD, and Jeremie Calais, MD, PhD.

We take a look back at the first three episodes of our new Molecular Imaging in Focus series with topics ranging from the potential of the emerging radiodiagnostic agent 61Cu-NU101 and recent findings from the Co-PSMA trial with 64Cu-SAR-bisPSMA to the utility of PSMA PET in risk stratification for patients with prostate cancer. Review the slideshow below to watch the first three episodes.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Subscribe

Related Content

Latest CME

25th Annual International Congress on the Future of Breast Cancer® East
Video

25th Annual International Congress on the Future of Breast Cancer® East

Joyce O’Shaughnessy, MD

View more
25th Annual International Congress on the Future of Breast Cancer® West
Video

25th Annual International Congress on the Future of Breast Cancer® West

Sara A. Hurvitz, MD, FACP; Joyce O’Shaughnessy, MD

View more
Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified
Multimedia

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

View more
Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care
Multimedia

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

View more